Taiwan · Delayed Price · Currency is TWD AP Biosciences Statistics
Total Valuation
AP Biosciences has a market cap or net worth of TWD 9.64 billion. The enterprise value is 7.50 billion.
| Market Cap | 9.64B |
| Enterprise Value | 7.50B |
Important Dates
The next estimated earnings date is Monday, August 24, 2026.
| Earnings Date | Aug 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AP Biosciences has 96.99 million shares outstanding. The number of shares has increased by 1.32% in one year.
| Current Share Class | 96.99M |
| Shares Outstanding | 96.99M |
| Shares Change (YoY) | +1.32% |
| Shares Change (QoQ) | +4.04% |
| Owned by Insiders (%) | 5.18% |
| Owned by Institutions (%) | 5.93% |
| Float | 55.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.15 |
| P/TBV Ratio | 4.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 57.66, with a Debt / Equity ratio of 0.02.
| Current Ratio | 57.66 |
| Quick Ratio | 56.46 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -394.63 |
Financial Efficiency
Return on equity (ROE) is -24.52% and return on invested capital (ROIC) is -16.56%.
| Return on Equity (ROE) | -24.52% |
| Return on Assets (ROA) | -16.33% |
| Return on Invested Capital (ROIC) | -16.56% |
| Return on Capital Employed (ROCE) | -21.80% |
| Weighted Average Cost of Capital (WACC) | 2.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.48% in the last 52 weeks. The beta is -0.36, so AP Biosciences's price volatility has been lower than the market average.
| Beta (5Y) | -0.36 |
| 52-Week Price Change | -20.48% |
| 50-Day Moving Average | 100.74 |
| 200-Day Moving Average | 146.24 |
| Relative Strength Index (RSI) | 47.67 |
| Average Volume (20 Days) | 318,542 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -517.36M |
| Pretax Income | -464.34M |
| Net Income | -464.34M |
| EBITDA | -500.92M |
| EBIT | -517.36M |
| Earnings Per Share (EPS) | -5.39 |
Balance Sheet
The company has 2.19 billion in cash and 53.73 million in debt, with a net cash position of 2.14 billion or 22.07 per share.
| Cash & Cash Equivalents | 2.19B |
| Total Debt | 53.73M |
| Net Cash | 2.14B |
| Net Cash Per Share | 22.07 |
| Equity (Book Value) | 2.33B |
| Book Value Per Share | 26.12 |
| Working Capital | 2.21B |
Cash Flow
In the last 12 months, operating cash flow was -365.80 million and capital expenditures -16.99 million, giving a free cash flow of -382.79 million.
| Operating Cash Flow | -365.80M |
| Capital Expenditures | -16.99M |
| Depreciation & Amortization | 16.44M |
| Net Borrowing | -11.51M |
| Free Cash Flow | -382.79M |
| FCF Per Share | -3.95 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AP Biosciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.32% |
| Shareholder Yield | -1.32% |
| Earnings Yield | -4.82% |
| FCF Yield | -3.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |